Kinnate Biopharma
San Diego, US · Founded 2018 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
SW
Stephen W. KaldorExecutive Officer, Director, Promoter
EM
Eric MurphyExecutive Officer, Director
BZ
Bret ZbarDirector
CG
Carl GordonDirector
MR
Michael RomeDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$98MraisedAug 2020 · 24 investors · BiotechnologyRule 506(b)
▶$98MraisedAug 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith FlahertyDirector
- Mark MeltzExecutive Officer
- Jim TananbaumDirector
- Dean MitchellDirector
- Stephen W. KaldorDirector, Promoter
- Carl GordonDirector
- Laurie Smaldone AlsupDirector
- Michael RomeDirector
- Nima FarzanExecutive Officer, Director
- Offering amount
- $98M
- Amount sold
- $98M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$74.5MraisedDec 2019 · 5 investors · PharmaceuticalsRule 506(b)
▶$74.5MraisedDec 2019 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen W. KaldorExecutive Officer, Director, Promoter
- Eric MurphyExecutive Officer, Director
- Bret ZbarDirector
- Carl GordonDirector
- Michael RomeDirector
- Offering amount
- $74.5M
- Amount sold
- $74.5M
- First sale
- Dec 2019
- Incorporated
- Corporation, California, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.